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cyclosporin A was suspected, but no clear aetiology Introduction and pathogenesis have been established. Methods. During the last 30 months we diagnosed the With the introduction of cyclosporin A (CsA) into the pain syndrome in 10 patients after renal transplanta-immunosuppressive therapy after renal transplantation. We prospectively followed and evaluated the tion, the incidence of avascular femoral head necroses patients during their clinical courses and through and therewith the total number of osseous complicapathological laboratory findings and magnetic reson-tions has markedly decreased [1] . It is generally ance imaging (MRI ).
accepted that this is due to lower doses of corticoResults. In all patients symptoms developed within 6 steroids in therapy regimens including CsA. months of transplantation after otherwise uncompliIn the last decade, symptoms of osteoarticular pain cated clinical courses without graft rejection episodes. of a type unknown in the pre-CsA era have come to Impressive bone-marrow oedema on MRI as well as the attention of clinicians [2] [3] [4] [5] [6] [7] [8] . Episodes of pain in elevated serum alkaline phosphatase was seen in all the distal lower limbs and knees are characteristically patients, and often exceeded the duration of clinical seen. The pain predominantly arises bilaterally and symptoms. All patients were instructed to avoid stress symmetrically within the first 2 years; however, most to the extremities through immobility, and steroid episodes occur several months after transplantation doses were tapered down. Within 14 weeks, eight and can lead to a drastic limitation in a patient's ability patients were free of symptoms. Two patients have to walk. Worsening has been observed under stress not experienced remission after 3 and 4 months res-and when standing, and occasionally a maximum pain pectively. None of the patients developed signs of intensity has been seen in resting states. Although longosteonecrosis.
term orthopaedic complications appear to be an excepConclusion. Post-transplant distal limb bone-marrow tion, the episodes of pain may persist from weeks oedema presents with distinct clinical findings and to months. signs of bone-marrow oedema on MRI. Proven standWithin the last 30 months we have observed this ard treatment does not exist. In our experience the pain syndrome with an increasing frequency in patients elevation of the extremities, the strict avoidance of receiving kidney allografts at our institution. The aim physical strain, and a stepwise withdrawal of steroids of the current study was to report the results of facilitates progressive disappearance of symptoms. different diagnostic imaging procedures as well as the Long-term damage to the affected osteal structures has clinical outcomes of a uniform therapeutic approach. not been seen, in contrast to avascular femoral-head necrosis.
all had an uncomplicated course after transplantation. A symmetrically at some point during the course in the spontaneous graft function was seen in all subjects postopera-areas of the forefeet, ankles, and/or knees. The chief tively. Immunosuppression was achieved with a regimen complaint was described as a constant dull pain that including CsA (trough level 170-210 ng/ml ), mycophenolate led to a noticeable impairment in mobility. All patients mofetil (1000 mg b.i.d.), and steroids (starting with 500 mg described worsening pain when standing and under during the operation, tapering to 10 mg/day within 5 stress, and relief of symptoms upon elevating the legs weeks). One patient was initially treated with antithymocyte-to a horizontal position.
globulin for prevention of acute rejection. Since rejection Except for mild soft-tissue swelling of the knees (two episodes were not observed in any patient, the cumulative patients) and/or the dorsal side of the feet (three steroid doses were relatively low and no further antibody treatment was necessary. After the onset of symptoms, a patients) combined with pain upon pressure, further detailed laboratory and diagnostic imaging work-up was clinical examination was unremarkable. In particular, performed. We prospectively followed and evaluated the there were no signs of acute arthritis, joint effusions, patients during their clinical courses and through documented or trophic or vasomotor changes in the involved areas changes on magnetic resonance imaging (MRI ), until of the extremities. remission.
Laboratory data Therapy
All patients had good transplant function with a mean serum creatinine of 1.5 mg/dl. The mean whole-blood Upon diagnosis, all patients were instructed to avoid all physical stress and practise strict immobility for relief. trough level of CsA during the time from transplantaPhysical therapy as well as low-molecular heparin s.c. were tion to the onset of symptoms was 211 ng/ml (range prescribed as a prophylaxis against thrombosis. In cases of 171-257). In four cases persistent hyperparathyroidism elevated CsA trough levels the dose was adjusted until a was seen after transplantation. All patients showed an target level of 150-180 ng/ml was reached. Two patients increase in levels of alkaline phosphatase with the were not able to follow the inactivity regimen for professional onset of pain. Analysis of isoenzymes demonstrated a reasons (Table 1, ( Table 1) . As an medication was tapered in all cases and subsequently withexample, Figure 1 shows the changes in alkaline phosdrawn in eight patients. Rejection episodes did not occur.
Furthermore, an attempt was made to treat the condition phatase and the clinical course of a 30-year-old patient with calcium-channel blockers (nifedipine in seven cases, after living-related renal transplantation.
nitrendipine in three cases).
Radiological findings
The initial radiographs were unremarkable in seven
Results
cases. In three patients a marked and diffuse, blotchy osteoporosis was diagnosed.
Clinical findings
An overview of the most important clinical data is Nuclear medicine findings shown in Table 1 . In all patients, symptoms developed within 6 months of renal transplantation while they A three-phase skeletal scintigraphy was obtained during the initial onset of symptoms in eight patients. were being treated with the above-mentioned triple immunosuppression (prednisone dose 5-10 mg/day at During the late phase an unusually symmetric and marked accumulation of the tracer substance was seen study time). All patients reported pain bilaterally and in the clinically affected areas of the knees, ankles, or During the course of the symptoms an average of 3 (2-6) MRI scans were obtained in each patient. In the forefeet. In four patients an additional accumulation in the early phase was noted in the same areas, early follow-up period varying patterns in the distribution of the oedematous areas were particularly noticeindicating soft-tissue involvement. Because of the largely symmetrical distribution, the lack of prior exam-able, i.e. regression was seen in the initially affected areas and newly affected areas were seen. Changes in inations, and the unspecific findings, a correct interpretation was only possible retrospectively in conjunc-MRI usually outlasted clinical symptoms. In seven patients residual bone-marrow oedema, though signition with the striking MRI findings of the patients.
ficantly diminished, was seen on follow-up MRI scans even after complete remission of clinical symptoms Magnetic resonance findings and normalization of alkaline phosphatase. In one The MRIs were made with either a 1 T-(Gyroscan patient ( Table 1, patient 2) residual oedema of the Philips, Eindhoven, Netherlands) or a 1.5 T ( Vision-calcaneus was detectable up to 1 year after the bone Siemens, Enlangen, Germany) scanner. Short TR/TE pain had remitted. ( T1-weighted images) as well as long TR/TE After a mean interval of 9 months (3-24) from the ( T2-weighted ), and fat suppressed (STIR, T2 Spir) first investigations, the final MRI scans to date showed sequences were evaluated. In all patients a replacement significant improvement but residual changes in six of fatty bone marrow with high intensity in T1 patients, complete remission in three patients, and weighted and T2 weighted images by marrow oedema worsening of morphological changes in one patient ( low signal intensity in T1-images, high signal intensity ( Table 1, patient 9), although his clinical symptoms in T2-images) was observed. As oedema contains more have improved over a subsequent course of 3 months. water molecules than the surrounding healthy bone None of the follow-up scans revealed changes suggestmarrow, the lesions became more evident on images ive of avascular osteonecrosis. obtained by fat suppression techniques.
The primary findings were thus seen as localized, Further clinical course patchy, oedematous changes, some of which included the entire bone ( Figure 2) . Neither a characteristic Following the above-described measures, symptoms persisted in six patients ( Table 1 , patients 1-6) for an distribution nor a characteristic course of the oedematous changes was seen in the patients. No joint effusions average of 13 weeks after the MRI diagnosis of posttransplant distal limb bone-marrow oedema was estabwere seen. In two cases an accompanying inflammatory reaction was visible in the surrounding soft tissue. A lished. In the two patients who were not able to follow the inactivity regimen ( Table 1 , patients 7 and 8), the demarcation of localized areas by hypointense bands on T1-or T2-weighted images characteristic of avascu-symptoms persisted for 5 and 6 months respectively. At this time, two patients (Table 1 , patients 9 and 10) lar osteonecrosis or impaction within cancellous bone [9, 10] , possibly putting the patients at risk of long-have experienced clinical improvement but not complete remission 3 and 4 months respectively after the term orthopaedic problems, was not observed in any case.
beginning of their symptoms. In one of these patients the bone-marrow oedema has worsened on MRI; both physical stress. This is probably the first description of the pain syndrome in a larger group of patients [2]. patients still have elevated levels of serum alkaline phosphatase. The other eight patients are followed
The aetiology and pathogenesis of the pain syndrome was not understood, but most authors suspected a regularly in our outpatient department. At the last follow-up visit, after a mean time of 23 months (3-36) relationship to CsA [3-5, 7, 13, 14] . Animal models have shown that dosage-dependent CsA use leads to an from the onset of clinical symptoms, all of them are free of complaints except for one 57-year-old patient increase in bone metabolism with evidence of osteoclasts in the tibial area of the animals [15] . Although who reports mild pain in both knees after long-distance walking. Considering the clinical outcome and the in vitro studies have led to contradictory results [16 ] , there appears to be a general acceptance that CsA has results of the final follow-up MRI scans in these eight patients, which showed either significant improvement some direct effect on bone metabolism. Our study patients initially showed slightly increased CsA trough or complete remission without signs of avascular osteonecrosis, there is no evidence of irreversible osse-levels. However, after lowering the levels (to 150-180 ng/ml ) at the onset of symptoms, the pain ous defects.
We did not see any effect from calcium-channel-did not subside. Even after exchanging CsA for tacrolblocker therapy. The exchange of tacrolimus ( FK506) imus in one patient because of gingival hyperplasia, for CsA in one patient, due to adverse side-effects, had the pain symptoms took several months to subside. no influence on the symptomatic pain. In this patient, Goffin, Vande-Berg and co-workers [17, 18] sugat a later point and after absolute avoidance of stress gested that the pain syndrome was due to epiphyseal to the extremities, the pain subsided within 4 weeks impaction of cortical bone, a hypothesis that could (Figure 1) . explain the character and length of clinical symptoms, the elevation of alkaline phosphatase, and the findings on diagnostic imaging. Many of our findings are Discussion comparable with the results reported by these authors, although we saw no linear bands of low-signal intensity on T1-and T2-weighted images consistent with occult A pain syndrome of the distal lower limbs after organ fractures, and no progression towards avascular transplantation has been previously described by sevosteonecrosis. Therefore, in our opinion the pathogeneral authors [2] [3] [4] [5] [6] [7] [8] . An elevation of alkaline phosphatesis of the syndrome remains to be elucidated. ase as a possible side-effect of CsA was known from MRI is the diagnostic measure of choice in affected the early use of this medication [11, 12] . Williams and patients. A higher sensitivity is achieved with MRI in co-workers reported on 19 patients with pain sympcomparison to the conventional plain film or skeletal toms that they termed 'symptomatic renal osteodysscintigraphy. In all our patients severe bone-marrow trophy' in 1987. The severe symptoms were limited exclusively to the lower extremities and worsened with oedema was documented. Considering the frequent osseous symptoms among transplant patients, e.g. per-the lower extremities. Since a few of these patients developed osteonecrosis, further discussion is needed sistent renal osteopathy or steroid-induced osteopenia, and the lack of a common definition of these pain to determine whether this syndrome is the same as post-transplant distal-limb bone-marrow oedema. The characteristics in the current literature, the evidence of our findings as seen by MRI should be conditional for authors reported rapid symptomatic relief and a prophylactic effect of nifedipine and other calcium-channel establishing the diagnosis of the syndrome.
Nevertheless one must bear in mind that bone-blockers such as amlodipine, felodipine, and isradipine. Twenty-one of 22 patients (95%) became virtually marrow oedema is generally unspecific and has been seen in sympathetic reflex dystrophy syndrome of the symptom free, some of them within minutes of the start of calcium-channel-blocker therapy. We cannot foot [19] , medial tibial pain in non-transplanted patients [20] , transient osteoporosis of the hip [21] , confirm these findings, as none of our patients experienced relief from this medication. Our therapeutic borderline necrosis or manifest avascular necrosis of the femoral head [9, [22] [23] [24] , and traumatic or stress strict avoidance of physical strain to the extremities in combination with the stepwise reduction of corticofractures of the calcaneus, tibia, knee, or shoulder [25] [26] [27] . Therefore only the association of the MRI steroids seemed reasonable because of patients' reports of symptomatic relief with rest and reports in the findings with bilateral lower limb pain, an almost normal physical examination, a rise in alkaline phos-literature that trauma-related epiphyseal trabecular bone impaction or insufficiency bone fractures may phatase, and possibly low cumulative steroid doses in post-renal-transplantation patients on CsA seems to accompany this syndrome [8, 17, 18] . Symptomatic improvement as well as the lack of development of be indicative of the syndrome. Thus, post-transplant distal-limb bone-marrow oedema can be seen as a irreversible osseous lesions may be secondary to the complete avoidance of physical strain to the extremities distinct clinical entity and be separated from the abovementioned conditions and especially from avascular with horizontal positioning as often as possible. Upon remission of symptoms only one patient was already osteonecrosis or reflex dystrophy syndrome.
Unlike avascular osteonecrosis [28] , the total dose steroid free; thus we do not attribute a clear effect to steroid reduction. of corticosteroids does not seem to pose a specific risk. None of our study patients was treated for acute rejection with high-dose steroids. During follow-up significant improvement or even complete remission Conclusion was seen on MR images along with clinical restitution in eight patients (Clinical outcomes in the other two We report the occurrence of severe osteoarticular pain patients is uncertain because of short follow-up involving the distal lower limbs, mainly knee and period). Hypointense bands in T1-or T2-weighted ankle, that developed within 6 months after renal images, indicative of avascular osteonecrosis and prob-transplantation in 10 of 158 renal transplant patients. ably preceding the bone-marrow oedema in this entity Increased uptake in long-bone epiphyses at scinti- [9] were not seen in any patient. In consideration of graphy and bone-marrow infiltration consistent with this finding and the clinical outcome of eight patients, bone-marrow oedema at MRI were consistently it is our impression that in contrast to avascular observed in symptomatic areas. We achieved progressosteonecrosis, long-term sequelae are at least unlikely ive disappearance of symptoms in eight of 10 patients in the majority of the patients. This impression is at last follow-up through therapeutic decreased weight consistent with the reports in the literature bearing and progressive lowering of steroid therapy. [3] [4] [5] 7, 17, 18, 29] , although progression to osteonecrosis in single patients cannot be excluded [6, 8, 17, 18] . by Munoz-Gomez and co-workers [13] . Although we The decreased incidence of aseptic necrosis in renal transplant recipients-a case control study. Transplantation 1986; 41:
were able to find very discrete soft-tissue swelling in [182] [183] [184] [185] [186] [187] [188] the affected areas in four patients, the typical signs of 
